Exercise
Conditions
Interventions
This is a randomized, controlled, two-arm, single-blind clinical trial that will include 56 older men aged between 65 and 79 years, diagnosed with type 2 diabetes mellitus, who will be randomly alloca
Sponsors
Universidade São Judas Tadeu
Universidade São Judas Tadeu
Eligibility
Sex/Gender
Male
Age
65 Years to 79 Years
Inclusion criteria
Inclusion criteria: Men; aged between 65 and 79 years; with type 2 Diabetes Mellitus with a stable dose of medication (oral antidiabetics or insulin or a combination of both) for three or more months; glycated hemoglobin between 6 and 10.0%; without musculoskeletal pain, disabling motor disorders, cardiovascular or musculoskeletal conditions that prevented the performance of resistance or combined training; had not participated in any resistance training or combined training practice at least three months before the start of the pre-intervention tests; normal cognitive level, assessed by the Montreal Cognitive Assessment (MoCA), respecting the cut-off levels according to the participant's education level
Exclusion criteria
Exclusion criteria: Impossibility of carrying out assessments and reassessments; during the training period they had more than three absences; they had any adverse events related to musculoskeletal pain or worsening of symptoms or signs of pre-existing diseases, mainly changes in systemic blood pressure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study will be the change in metabolic profile in older adults with type 2 diabetes after 12 weeks of intervention with resistance and combined training. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anthropometry and body composition will be assessed using bioelectrical impedance ;Muscle strength will be evaluated through one-repetition maximum (1RM) testing and handgrip strength;Physical performance will be measured using the Senior Fitness Test, the Timed Up and Go (TUG) test, and the Short Physical Performance Battery (SPPB);Advanced glycation end products (AGEs) will be measured using a fluorescent AGE reader | — |
Countries
Brazil
Contacts
Public ContactAngelica Alonso
Universidade São Judas Tadeu
Outcome results
None listed